Motivational effects of cannabinoids and opioids on food reinforcement depend on simultaneous activation of cannabinoid and opioid systems

Neuropsychopharmacology

Volumn 30, Issue 11, 2005, Pages 2035-2045

  Solinas, Marcello ^a,b   Goldberg, Steven R ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b UNIVERSITÉ DE POITIERS   (France)

Author keywords

Anorexigenic; Appetite; Cannabis; Obesity; Opiates; Progressive ratio

Indexed keywords

CANNABINOID; CANNABINOID 1 RECEPTOR; CANNABINOID RECEPTOR; CANNABINOID RECEPTOR ANTAGONIST; DRONABINOL; MORPHINE; MU OPIATE RECEPTOR ANTAGONIST; NALOXONE; OPIATE AGONIST; OPIATE RECEPTOR; RIMONABANT;

ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR; CONTROLLED STUDY; DRUG EFFECT; EATING DISORDER; FEEDING; FOOD DEPRIVATION; FOOD INTAKE; MALE; MOTIVATION; NONHUMAN; PERFORMANCE; PRIORITY JOURNAL; RAT; RECEPTOR UPREGULATION; REINFORCEMENT;

ANALGESICS, NON-NARCOTIC; ANALGESICS, OPIOID; ANALYSIS OF VARIANCE; ANIMALS; BEHAVIOR, ANIMAL; CANNABINOIDS; CENTRAL NERVOUS SYSTEM STIMULANTS; CONDITIONING, OPERANT; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG COMBINATIONS; DRUG INTERACTIONS; EATING; FOOD; FOOD DEPRIVATION; MALE; METHAMPHETAMINE; MORPHINE; MOTIVATION; NARCOTICS; PIPERIDINES; PYRAZOLES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CANNABINOID; RECEPTORS, OPIOID; REINFORCEMENT (PSYCHOLOGY); REINFORCEMENT SCHEDULE; TETRAHYDROCANNABINOL; TIME FACTORS;

EID: 20444399986     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.npp.1300720     Document Type: Article

References (69)

1. Abel EL (1975). Cannabis: effects on hunger and thirst. Behav Biol 15: 255-281.
2. Arnold JM, Roberts DC (1997). A critique of fixed and progressive ratio schedules used to examine the neural substrates of drug reinforcement. Pharmacol Biochem Behav 57: 441-447.
3. Arnone M, Maruani J, Chaperon F, Thiebot MH, Poncelet M, Soubrie P et al (1997). Selective inhibition of sucrose and ethanol intake by SR 141716, an antagonist of central cannabinoid (CB1) receptors. Psychopharmacology (Berl) 132: 104-106.
4. 35S]-GTPgammaS binding in the brain of mu-, delta- and kappa-opioid receptor knockout mice. Eur J Neurosci 18: 2197-2202.
5. Berry EM, Mechoulam R (2002). Tetrahydrocannabinol and endocannabinoids in feeding and appetite. Pharmacol Ther 95: 185-190.
6. Chen JP, Paredes W, Li J, Smith D, Lowinson J, Gardner EL (1990). Delta 9-tetrahydrocannabinol produces naloxone-blockable enhancement of presynaptic basal dopamine efflux in nucleus accumbens of conscious, freely-moving rats as measured by intracerebral microdialysis. Psychopharmacology (Berl) 102: 156-162.
7. Colombo G, Agabio R, Diaz G, Lobina C, Reali R, Cessa GL (1998). Appetite suppression and weight loss after the cannabinoid antagonist SR 141716. Life Sci 63: PL113-117.
8. Cooper SJ (2004). Endocannabinoids and food consumption: comparisons with benzodiazepine and opioid palatability-dependent appetite. Eur J Pharmacol 500: 37-49.
9. Cooper SJ, Kirkham TC (1990). Basic mechanisms of opioids' effects on eating and drinking. In: Reid LD (ed). Opioids, Bulimia and Alcohol Abuse and Alcoholism. Springer: New York. pp 91-110.
10. Cossu G, Ledent C, Fattore L, Imperato A, Bohme GA, Parmentier M et al (2001). Cannabinoid CB1 receptor knockout mice fail to self-administer morphine but not other drugs of abuse. Behav Brain Res 118: 61-65.
11. Cota D, Marsicano G, Lutz B, Vicennati V, Stalla GK, Pasquali R et al (2003). Endogenous cannabinoid system as a modulator of food intake. Int J Obes Relat Metab Disord 27: 289-301.
12. Croxford JL (2003). Therapeutic potential of cannabinoids in CNS disease. CNS Drugs 17: 179-202.
13. De Vries TJ, Shaham Y, Homberg JR, Crombag H, Schuurman K, Dieben J et al (2001). A cannabinoid mechanism in relapse to cocaine seeking. Nat Med 7: 1151-1154.
14. Di Marzo V, Goparaju SK, Wang L, Liu J, Batkai S, Jarai Z et al (2001). Leptin-regulated endocannabinoids are involved in maintaining food intake. Nature 410: 822-825.
15. Fernandez JR, Allison DB (2004). Rimonabant Sanofi-Synthelabo. Curr Opin Invest Drugs 5: 430-435.
16. Freedland CS, Poston JS, Porrino LJ (2000). Effects of SR141716A, a central cannabinoid receptor antagonist, on food-maintained responding. Pharmacol Biochem Behav 67: 265-270.
17. Gallate JE, Saharov T, Mallet PE, McGregor IS (1999). Increased motivation for beer in rats following administration of a cannabinoid CB1 receptor agonist. Eur J Pharmacol 370: 233-240.
18. Gonzalez S, Manzanares J, Berrendero F, Wenger T, Corchero J, Bisogno T et al (1999). Identification of endocannabinoids and cannabinoid CB(1) receptor mRNA in the pituitary gland. Neuroendocrinology 70: 137-145.
19. Gonzalez S, Schmid PC, Fernandez-Ruiz J, Krebsbach R, Schmid HH, Ramos JA (2003). Region-dependent changes in endocannabinoid transmission in the brain of morphine-dependent rats. Addict Biol 8: 159-166.
20. Gosnell B, Levine AS (1996). Stimulation of ingestive behaviour by preferential and selective opioid agonists. In: Cooper SJ and Clifton PG (eds). Drug Receptor Subtypes and Ingestive Behaviour. Academic Press: San Diego. pp 147-166.
21. Griffiths RR, Findley JD, Brady JV, Dolan-Gutcher K, Robinson WW (1975). Comparison of progressive-ratio performance maintained by cocaine, methylphenidate and secobarbital. Psychopharmacologia 43: 81-83.
22. Hao S, Avraham Y, Mechoulam R, Berry EM (2000). Low dose anandamide affects food intake, cognitive function, neurotransmitter and corticosterone levels in diet-restricted mice. Eur J Pharmacol 392: 147-156.
23. Harrold JA, Williams G (2003). The cannabinoid system: a role in both the homeostatic and hedonic control of eating? Br J Nutr 90: 729-734.
24. Herkenham M, Lynn AB, Johnson MR, Melvin LS, de Costa BR, Rice KC (1991). Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study. J Neurosci 11: 563-583.
25. Higgs S, Williams CM, Kirkham TC (2003). Cannabinoid influences on palatability: microstructural analysis of sucrose drinking after delta(9)-tetrahydrocannabinol, anandamide, 2-arachidonoyl glycerol and SR141716. Psychopharmacology (Berl) 165: 370-377.
26. Hodos W (1961). Progressive ratio as a measure of reward strength. Science 134: 943-944.
27. Holtzman SG, Jewett RE (1973). Stimulation of behavior in the rat by cyclazocine: effects of naloxone. J Pharmacol Exp Ther 187: 380-390.
28. Howlett AC (2002). The cannabinoid receptors. Prostaglandins Other Lipid Mediat 68-69: 619-631.
29. Jamshidi N, Taylor DA (2001). Anandamide administration into the ventromedial hypothalamus stimulates appetite in rats. Br J Pharmacol 134: 1151-1154.
30. Jarbe TU, Andrzejewski ME, DiPatrizio NV (2002). Interactions between the CB1 receptor agonist delta 9-THC and the CB1 receptor antagonist SR-141716 in rats: open-field revisited. Pharmacol Biochem Behav 73: 911-919.
31. Justinova Z, Tanda G, Munzar P, Goldberg SR (2004). The opioid antagonist naltrexone reduces the reinforcing effects of delta 9 tetrahydrocannabinol (THC) in squirrel monkeys. Psychopharmacology (Berl) 173: 186-194.
32. Kalinichev M, White DA, Holtzman SG (2004). Individual differences in locomotor reactivity to a novel environment and sensitivity to opioid drugs in the rat. I. Expression of morphine-induced locomotor sensitization. Psychopharmacology (Berl) 177: 61-67.
33. Kelley AE, Bakshi VP, Haber SN, Steininger TL, Will MJ, Zhang M (2002). Opioid modulation of taste hedonics within the ventral striatum. Physiol Behav 76: 365-377.
34. Kirkham TC (2003). Endogenous cannabinoids: a new target in the treatment of obesity. Am J Physiol Regul Integr Comp Physiol 284: R343-344.
35. Kirkham TC, Williams CM (2001). Synergistic efects of opioid and cannabinoid antagonists on food intake. Psychopharmacology (Berl) 153: 267-270.
36. Ledent C, Valverde O, Cossu G, Petitet F, Aubert JF, Beslot F et al (1999). Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice. Science 283: 401-404.
37. Low MJ, Hayward MD, Appleyard SM, Rubinstein M (2003). State-dependent modulation of feeding behavior by proopiomelanocortin-derived beta-endorphin. Ann NY Acad Sci 994: 192-201.
38. Mansour A, Khachaturian H, Lewis ME, Akil H, Watson SJ (1987). Autoradiographic differentiation of mu, delta, and kappa opioid receptors in the rat forebrain and midbrain. J Neurosci 7: 2445-2464.
39. Manzanares J, Corchero J, Romero J, Fernandez-Ruiz JJ, Ramos JA, Fuentes JA (1999). Pharmacological and biochemical interactions between opioids and cannabinoids. Trends Pharmacol Sci 20: 287-294.
40. Martin M, Ledent C, Parmentier M, Maldonado R, Valverde O (2000). Cocaine, but not morphine, induces conditioned place preference and sensitization to locomotor responses in CB1 knockout mice. Eur J Neurosci 12: 4038-4046.
41. Mascia MS, Obinu MC, Ledent C, Parmentier M, Bohme GA, Imperato A et al (1999). Lack of morphine-induced dopamine release in the nucleus accumbens of cannabinoid CB(1) receptor knockout mice. Eur J Pharmacol 383: R1-R2.
42. Matsuda LA, Lolait SJ, Brownstein MJ, Young AC, Bonner TI (1990). Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 346: 561-564.
43. McLaughlin PJ, Winston K, Swezey L, Wisniecki A, Aberman J, Tardif DJ et al (2003). The cannabinoid CB1 antagonists SR 141716A and AM 251 suppress food intake and food-reinforced behavior in a variety of tasks in rats. Behav Pharmacol 14: 583-588.
44. Munzar P, Tanda G, Justinova Z, Goldberg SR (2004). Histamine h3 receptor antagonists potentiate methamphetamine self-administration and methamphetamine-induced accumbal dopamine release. Neuropsychopharmacology 29: 705-717.
45. National Research Council (2003). Guidelines for the Care and Use of Mammals in Neuroscience and Behavioral Research. The National Academy Press: Washington, DC, USA.
46. Nencini P, Graziani M (1990). Opiatergic modulation of preparatory and consummatory components of feeding and drinking. Pharmacol Biochem Behav 37: 531-537.
47. Piomelli D (2003). The molecular logic of endocannabinoid signalling. Nat Rev Neurosci 4: 873-884.
48. Reisine T, Law SF, Blake A, Tallent M (1996). Molecular mechanisms of opiate receptor coupling to G proteins and effector systems. Ann NY Acad Sci 780: 168-175.
49. Robbins TW, Watson BA, Gaskin M, Ennis C (1983). Contrasting interactions of pipradrol, D-amphetamine, cocaine, cocaine analogues, apomorphine and other drugs with conditioned reinforcement. Psychopharmacology (Berl) 80: 113-119.
50. Roberts DC, Bennett SA (1993). Heroin self-administration in rats under a progressive ratio schedule of reinforcement. Psychopharmacology (Berl) 111: 215-218.
51. Rodriguez JJ, Mackie K, Pickel VM (2001). Ultrastructural localization of the CB1 cannabinoid receptor in mu-opioid receptor patches of the rat caudate putamen nucleus. J Neurosci 21: 823-833.
52. Rowland NE, Mukherjee M, Robertson K (2001). Effects of the cannabinoid receptor antagonist SR 141716, alone and in combination with dexfenfluramine or naloxone, on food intake in rats. Psychopharmacology (Berl) 159: 111-116.
53. Salamone JD, Correa M, Mingote S, Weber SM (2003). Nucleus accumbens dopamine and the regulation of effort in food-seeking behavior: implications for studies of natural motivation, psychiatry, and drug abuse. J Pharmacol Exp Ther 305: 1-8.
54. Schmelzeis MC, Mittleman G (1996). The hippocampus and reward: effects of hippocampal lesions on progressive-ratio responding. Behav Neurosci 110: 1049-1066.
55. Simiand J, Keane M, Keane PE, Soubrie P (1998). SR 141716, a CB1 cannabinoid receptor antagonist, selectively reduces sweet food intake in marmoset. Behav Pharmacol 9: 179-181.
56. Solinas M, Panlilio LV, Antoniou K, Pappas LA, Goldberg SR (2003). The cannabinoid CB1 antagonist N-piperidinyl-5-(4-chlorophenyl)-1-(2,4- dichlorophenyl)-4-methylpyrazole-3-carbox-amide (SR-141716A) differentially alters the reinforcing effects of heroin under continuous reinforcement, fixed ratio, and progressive ratio schedules of drug self-administration in rats. J Pharmacol Exp Ther 306: 93-102.
57. Solinas M, Zangen A, Thiriet N, Goldberg SR (2004). Beta-endorphin elevations in the ventral tegmental area regulate the discriminative effects of delta-9-tetrahydrocannabinol. Eur J Neurosci 19: 3183-3192.
58. Spano MS, Fattore L, Cossu G, Deiana S, Fadda P, Fratta W (2004). CB1 receptor agonist and heroin, but not cocaine, reinstate cannabinoid-seeking behaviour in the rat. Br J Pharmacol 143: 343-350.
59. Tanda G, Goldberg SR (2003). Cannabinoids: reward, dependence, and underlying neurochemical mechanisms - a review of recent preclinical data. Psychopharmacology (Berl) 169: 115-134.
60. Tanda G, Pontieri FE, Di Chiara G (1997). Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common mu1 opioid receptor mechanism. Science 276: 2048-2050.
61. Thornton-Jones ZD, Vickers SP, Clifton PG (2004). The cannabinoid CB1 receptor antagonist SR141716A reduces appetitive and consummatory responses for food. Psychopharmacology (Berl) (online); doi: 10.1007/s00213-004-2047-8.
62. Valverde O, Noble F, Beslot F, Dauge V, Fournie-Zaluski MC, Roques BP (2001). Delta9-tetrahydrocannabinol releases and facilitates the effects of endogenous enkephalins: reduction in morphine withdrawal syndrome without change in rewarding effect. Eur J Neurosci 13: 1816-1824.
63. Vigano D, Grazia Cascio M, Rubino T, Fezza F, Vaccani A, Di Marzo V et al (2003). Chronic morphine modulates the contents of the endocannabinoid, 2-arachidonoyl glycerol, in rat brain. Neuropsychopharmacology 28: 1160-1167.
64. Vigano D, Valenti M, Cascio MG, Di Marzo V, Parolaro D (2004). Changes in endocannabinoid levels in a rat model of behavioral sensitization to morphine. Eur J Neurosci 20: 1849-1857.
65. Williams CM, Kirkham TC (1999). Anandamide induces overeating: mediation by central cannabinoid (CB1) receptors. Psychopharmacology (Berl) 143: 315-317.
66. Williams CM, Kirkham TC (2002a). Observational analysis of feeding induced by Delta9-THC and anandamide. Physiol Behav 76: 241-250.
67. Williams CM, Kirkham TC (2002b). Reversal of delta 9-THC hyperphagia by SR141716 and naloxone but not dexfenfluramine. Pharmacol Biochem Behav 71: 333-340.
68. Williams CM, Rogers PJ, Kirkham TC (1998). Hyperphagia in prefed rats following oral delta9-THC. Physiol Behav 65: 343-346.
69. Yeomans MR, Gray RW (2002). Opioid peptides and the control of human ingestive behaviour. Neurosci Biobehav Rev 26: 713-728.